W. Brenner et al., Comparison between the expression of adhesion molecules in the endotheliumof renal cell carcinomas and healthy kidney tissue, AKT UROL, 30(6), 1999, pp. 410-415
Purpose: Spontaneous remission of renal cell carcinoma is a relatively freq
uently observed event compared with other tumor entities usually associated
with a high accumulation of tumor infiltrating lymphocytes (TIL) in the tu
mor tissue. The lymphocyte infiltrative in renal cell carcinoma shows a dif
ferent composition of subclasses compared to peripheral blood and a higher
concentration than in normal renal tissue, suggesting selective tumor invas
ion. The first step in an immunological reaction to renal cell carcinoma is
the extravasation of TIL into the malignant tissue, which is mediated by a
dhesion molecules. We examined the different expression of the adhesion mol
ecule endothelial-leukocyte-adhesion-molecule-1 (ELAM-1) on endothelial cel
ls of RCC and normal renal tissue.
Materials and Methods: For a specific quantification of ELAM1 in renal cell
carcinoma and the corresponding normal renal tissue, the level of ELAM-1 m
RNA in frozen sections of 10 patients was investigated by both semiquantita
tive RT-PCR and Northern blot and referred to the content of endothelial ce
lls in the tissue, determined by endothelium-specific staining. Quantificat
ion of mRNA was performed by a computer-based densitometric integration.
Results: We observed a tenfold lower content of endothelial cells in RCC co
mpared to normal renal tissue. The specific transcription rate of ELAM-1 in
renal cell carcinoma as determined by RT-PCR was about 5.2 times higher th
an normal renal tissue, and, as determined by Northern blot it was about 11
.8 times higher.
Conclusions: Our investigations show a significantly increased expression o
f ELAM-1 in tumor tissue as compared to normal renal tissue in the same pat
ient, presumably caused by a higher amount of cytokines in tumor tissue. Th
is enhanced expression may be responsible for the high concentration of TIL
in renal tumors.